Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-01-501750
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d25257_10k.txt 10-K 213558
2 DR. ELKAN R. GAMZU AGREEMENT d25257_ex10-n.txt EX-10.(N) 2931
3 DR. STEPHEN C. KNIGHT AGREEMENT d25257_ex10-o.txt EX-10.(O) 3174
4 MR. MARVIN P. LOEB AGREEMENT d25257_ex10-p.txt EX-10.(P) 2883
5 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS d25257_ex23-a.txt EX-23.(A) 591
  Complete submission text file 0000891554-01-501750.txt   225241
Mailing Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

EIN.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-11550 | Film No.: 1588383
SIC: 2834 Pharmaceutical Preparations